Improvement in recurring nivolumab-induced pneumonitis with repetitive administration of infliximab in a patient with head and neck cancer: A case report

Severe pneumonitis induced by nivolumab, an anti-programmed cell death-1 monoclonal antibody, is a rare but potentially fatal immune-related adverse event. In cases of steroid-refractory pneumonitis, an appropriate therapeutic strategy using anti-tumor necrosis factor-α (TNF-α) antibody has not been...

Descripción completa

Detalles Bibliográficos
Autores principales: Ueno, Shohei, Uenomachi, Masato, Kusaba, Hitoshi, Ito, Mamoru, Suzuki, Kunihiro, Ohmura, Hirofumi, Tsuchihashi, Kenji, Ariyama, Hiroshi, Akashi, Koichi, Baba, Eishi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8408681/
https://www.ncbi.nlm.nih.gov/pubmed/34476105
http://dx.doi.org/10.3892/mco.2021.2379

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8408681/
https://www.ncbi.nlm.nih.gov/pubmed/34476105
http://dx.doi.org/10.3892/mco.2021.2379

Ejemplares similares